ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
33 announcements with these filters
CARE Ratings reaffirmed Artemis Medicare's bank facility ratings at CARE A with Stable outlook. Long-term and short-term facilities totalling ₹388.15 Cr were reviewed.
Artemis reports strong Q1 FY27 growth, driven by Gurgaon performance and the Raipur hospital launch. Management is pivoting toward high-end quaternary care with a massive 2,000-bed expansion target by 2030.
Artemis Medicare Services will invest ₹180 Crore to add 200+ beds at its Gurugram hospital, focusing on pediatric and gynecological services.
Artemis Medicare Services filed its Monitoring Agency Report for the quarter ended June 30, 2026, regarding the utilization of proceeds from its past Preferential Issue.
Artemis Medicare Services reported Q1 FY27 consolidated revenue of ₹287.32 Crore, up 12.7% YoY. Operational milestones include the new Raipur hospital launch.
Artemis reports strong Q1 FY27 results with consolidated revenue up 12.7% YoY to INR 28,732 Lacs and PAT growing 48.3%. Growth is driven by core hospital operations and high-acuity clinical mix.
Artemis Medicare Services Ltd reported revenue from operations of ₹287.3 Cr (+12.7% YoY) and net profit of ₹31.4 Cr (+48.1% YoY) for Q1 FY27.
Artemis Medicare Services Ltd shareholders approved the appointment of Dr. Girdhar Jessaram Gyani as an Independent Director for a three-year term at its 22nd AGM.
Artemis Medicare Services Ltd held its 22nd Annual General Meeting on July 31, 2026, where shareholders considered various ordinary and special business items.
Artemis Medicare Services Ltd scheduled a board meeting for August 3, 2026. The board will consider the unaudited financial results for the quarter ended June 30, 2026.
Artemis Medicare Services Ltd announced voting results from a postal ballot. Shareholders approved a special resolution to raise funds via equity shares or other securities.
Artemis Medicare Services Ltd launched Artemis Shanti Hospital, a 300-bed multi‑specialty facility in Raipur, effective July 9 2026. The hospital expands the group's healthcare footprint in Central India.
Artemis Medicare filed its BRSR for FY 2025-26, detailing ESG performance and operations. The report covers 3 hospitals and 1,677 workers, with no financial or corporate action disclosed.
Artemis Medicare Services Ltd announces its 22nd AGM on July 31, 2026. Agenda includes adopting FY25-26 financials, declaring a Rs.0.45 dividend, and appointing directors.
Artemis Medicare Services approved raising up to ₹700 Crore through equity or other securities. The company will seek shareholder approval via postal ballot for this capital exercise.
Artemis Medicare Services scheduled a board meeting on June 4, 2026, to discuss a Rs. 700 Crore fund raise. The meeting focuses on approving the postal ballot notice.
Artemis Medicare submitted its Annual Secretarial Compliance Report for FY2026. The report confirms overall compliance with SEBI regulations, noting resolution of a minor prior reporting delay.
Artemis Medicare delivered strong FY26 results with consolidated revenue of ₹1,081 Cr, up 15.4% YoY. Strategy focuses on expanding bed capacity and high-end quaternary care.
Artemis Medicare delivered a solid FY26 with 15.4% revenue growth, driven by core specialties and improved case mix. Management is aggressively expanding bed capacity from 800 to 2,000 by 2029.
Artemis Medicare Services announced the tenure completion of Independent Director Sunil Tandon on May 9, 2026. This departure follows standard regulatory rotation and governance cycles.
Artemis Medicare Services submitted its Monitoring Agency Report for the quarter ended March 2026. The company utilized ₹136.89 Crore of its ₹330 Crore preferential issue proceeds.
Artemis Medicare Services appointed Mr. Tapan Mitra as an Independent Director for three years. He brings 40 years of HR leadership experience from Apollo Tyres.
Artemis Medicare Services reported strong FY26 performance with 15.4% consolidated revenue growth and 26.2% PAT growth. Strategy focuses on bed capacity expansion and high-end tertiary care.
Artemis Medicare Services recommended a final dividend of ₹0.45 per equity share. The Board authorized the Chairman to finalize the AGM and record dates.
Artemis Medicare Services Ltd has updated its fair disclosure code for unpublished price sensitive information. The Board-approved amendments strengthen internal governance and regulatory compliance.
Artemis Medicare reported FY26 consolidated revenue of ₹1,081.24 Crore, up 15.4%. Strong operational growth and international patient contributions drove net profit up 26.2% annually.
Artemis Medicare Services reported a strong FY26 with consolidated revenue growing 15.4% and PAT surging 26.2%. The company is executing a major expansion strategy to reach ~2,000 beds by 2028.
Artemis Medicare Services Ltd reported revenue from operations of ₹279.2 Cr (+16.4% YoY) and net profit of ₹30.3 Cr (+32.3% YoY) for Q4 FY26.
Artemis Medicare Services approved its FY26 audited financial results and recommended a 45% final dividend. The board also appointed two new Independent Directors.
Artemis Medicare Services Limited has scheduled a board meeting for May 8, 2026. The board will consider audited standalone and consolidated financial results for the year ended March 31, 2026, and a proposal for a final dividend. The trading window is currently closed until May 10, 2026.